Glades Pharmaceuticals names new president

As president, Mr Cunard will be responsible for all company activities including daily operations, strategy and business development activities related to the organization’s commercial initiatives.

Before coming to Glades, Mr Cunard spent seven years with Mylan Pharmaceuticals in various management capacities, with the last position held as senior vice president of marketing and strategic development.

Bill Humphries, president of Stiefel, said: “We are delighted to have someone as accomplished as Bob leading Glades. His extensive experience in the generic pharmaceutical industry coupled with his vast understanding of business development makes him the ideal choice for this position at Glades, where the three-pronged business model focuses on internal development, strategic alliances and select product opportunities.”